Mukund Paravasthu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mukund Paravasthu
Mukund Paravasthu is recorded as COO at NovoCure Ltd (NVCR). NovoCure Ltd reported in an 8-K filed October 30, 2024 that Mukund Paravasthu was appointed Chief Operating Officer, effective October 1, 2024. NovoCure Ltd reported in an 8-K filed September 3, 2024 that Mukund Paravasthu was appointed Chief Operating Officer, effective October 1, 2024.
“In addition, we announced the promotion of Mukund Paravasthu to the role of Chief Operating Officer, effective October 1, 2024.”
“Mukund Paravasthu, who joined Novocure in 2020 and currently holds the position of Senior Vice President, Product Development, will expand his current responsibilities and transition into the role of COO.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at NovoCure Ltd
Other people whose current roles at this company are on record from its filings.
- Asaf Danziger CEO, Board Member
- David Hung CEO, Board Member
- Frank Leonard CEO, Board Member
- William Vernon CEO, Board Member
- Kinyip Gabriel Leung Chairman, Board Member
- William Doyle Chairman, Board Member
- Christoph Brackmann CFO
- Jeryl Hilleman CFO, Board Member
- Kristin Stafford CFO, Chief Accounting Officer, Board Member
- Timothy Scannell COO, Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.